{"meta":{"query_hash":"24ababab392c","filters":{"venue":"Current Drug Targets - CNS & Neurological Disorders"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/24ababab392c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Drug+Targets+-+CNS+%26+Neurological+Disorders"},"results":[{"id":"W1985778670","doi":"10.2174/156800705774322067","title":"Abeta Immunotherapy and Other Means to Remove Amyloid","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Presenilin; Genetically modified mouse; Alzheimer's disease; Amyloid precursor protein; Transgene; Amyloid (mycology); Immunotherapy; Amyloid beta; Disease; Medicine; Chemistry; Immunology; Immune system; Biochemistry; Pathology","score_opus":0.05743566858691119,"score_gpt":0.3751797894650004,"score_spread":0.31774412087808923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985778670","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064953015,0.9945117,0.00038427475,0.00026394954,0.00027396827,0.000016861826,0.00002098092,0.000021125721,0.0038575763],"genre_scores_gemma":[0.0036775924,0.9898509,0.00072287925,0.00040351468,0.00022804277,0.000030315163,0.00006877018,0.0000041795224,0.005013868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998851,0.000019465864,0.000011516459,0.000022129438,0.00004920463,0.000012487475],"domain_scores_gemma":[0.99994516,0.000018473076,0.000009587335,0.000004370063,0.000014079036,0.00000844302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027078312,0.0007656917,0.001321096,0.002023136,0.00033826535,0.0007115541,0.0007146751,0.0010635032,0.005307667],"category_scores_gemma":[0.00020781513,0.00018069199,0.00048545995,0.001383292,0.0003908173,0.00089033064,0.00042366842,0.001494557,0.004579254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001219477,0.00040116024,0.0001574403,0.007751312,0.00008916516,0.000630399,0.00008285198,0.0002727811,0.012353342,0.004536324,0.015203428,0.95839983],"study_design_scores_gemma":[0.000065277476,0.0003175982,0.0011379204,0.0014496252,0.00008343417,0.0032561263,0.00006362888,0.000093439616,0.0053644404,0.0036825137,0.9844667,0.00001944015],"about_ca_topic_score_codex":0.000556864,"about_ca_topic_score_gemma":0.0010892935,"teacher_disagreement_score":0.005307667,"about_ca_system_score_codex":0.000369839,"about_ca_system_score_gemma":0.00041996207,"threshold_uncertainty_score":0.017755926},"labels":[],"label_agreement":null},{"id":"W1987897200","doi":"10.2174/1568007053544183","title":"NMDA/NR2B Selective Antagonists in the Treatment of Ischemic Brain Injury","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ifenprodil; NMDA receptor; Neuroprotection; Glutamate receptor; Neuroscience; Medicine; Pharmacology; Receptor; Neurotransmission; Biology; Internal medicine","score_opus":0.09252142624873262,"score_gpt":0.4242557918291176,"score_spread":0.331734365580385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987897200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001488577,0.99429506,0.00039257205,0.00019840803,0.00016118419,0.000018889295,0.000031098098,0.0000268144,0.0033874798],"genre_scores_gemma":[0.0037778497,0.99310946,0.0006447114,0.00020640636,0.00013993337,0.000019441084,0.000065738495,0.0000031680058,0.0020333554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998951,0.000017760158,0.00001459972,0.00001610357,0.00004392672,0.000012509853],"domain_scores_gemma":[0.99994016,0.000015709007,0.000012792238,0.0000023773077,0.000019449346,0.000009565214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030928932,0.00073765207,0.0012692877,0.0011970954,0.00018842662,0.00031464457,0.0007885713,0.00063877914,0.0031735846],"category_scores_gemma":[0.0001912773,0.00015407456,0.00031428214,0.0012260502,0.00022788571,0.00047392526,0.00024007133,0.0008447301,0.0027455885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019855333,0.00023962803,0.00020008368,0.0075522214,0.0000749387,0.00066030043,0.00006912037,0.0003973383,0.0138214715,0.0012905893,0.016344596,0.9591511],"study_design_scores_gemma":[0.00020113015,0.0010347894,0.0045570196,0.0022652731,0.00023792044,0.0073221847,0.00010385403,0.00033488733,0.0077991695,0.001802332,0.9743056,0.000035818637],"about_ca_topic_score_codex":0.00060771266,"about_ca_topic_score_gemma":0.0017436194,"teacher_disagreement_score":0.0031735846,"about_ca_system_score_codex":0.0003272422,"about_ca_system_score_gemma":0.00038899505,"threshold_uncertainty_score":0.01061672},"labels":[],"label_agreement":null},{"id":"W2005425566","doi":"10.2174/156800705774322085","title":"Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pathogenesis; Disease; Apolipoprotein E; Alzheimer's disease; Medicine; Cholesterol; Apolipoprotein B; Bioinformatics; Immunology; Internal medicine; Biology","score_opus":0.0708535222575065,"score_gpt":0.36555977612965285,"score_spread":0.29470625387214633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005425566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014899259,0.99714893,0.00015882883,0.00075713155,0.00029564157,0.0000045781826,0.000009710053,0.000009837,0.0014663225],"genre_scores_gemma":[0.00078587426,0.9964561,0.0003489122,0.0004943905,0.00024362249,0.000008266927,0.000021801106,0.0000016474451,0.0016392651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997979,0.000044190423,0.000022941964,0.000027097076,0.00008625833,0.000021720683],"domain_scores_gemma":[0.999775,0.00008490952,0.000026971595,0.000010095374,0.00006930285,0.000033861623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006761337,0.0008386021,0.0016219274,0.0015527685,0.00038798287,0.0009736361,0.00078572694,0.0019107432,0.004514659],"category_scores_gemma":[0.00048593016,0.000249281,0.00045530897,0.0013485606,0.00047732942,0.0015690619,0.0005619496,0.0021574076,0.0041515413],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012731667,0.0001654653,0.00017789255,0.0065984135,0.0000794727,0.000503823,0.00006646483,0.0003268977,0.003488981,0.0065471046,0.048400294,0.9335178],"study_design_scores_gemma":[0.00004965953,0.00014802231,0.0006321499,0.0024397601,0.00006627547,0.001404655,0.00006913546,0.00008636256,0.0005972682,0.0038125976,0.99067885,0.000015306552],"about_ca_topic_score_codex":0.0008851447,"about_ca_topic_score_gemma":0.0019786167,"teacher_disagreement_score":0.004514659,"about_ca_system_score_codex":0.0006642073,"about_ca_system_score_gemma":0.0009953371,"threshold_uncertainty_score":0.015103042},"labels":[],"label_agreement":null},{"id":"W2056349137","doi":"10.2174/1568007043337076","title":"Exercise in a Pill: Feasibility of Energy Expenditure Targets","year":2004,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Energy, Environment, and Transportation Policies","field":"Energy","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Pill; Energy expenditure; Energy metabolism; Medicine; Pharmacology; Internal medicine","score_opus":0.035012071385641434,"score_gpt":0.3033825570588669,"score_spread":0.26837048567322547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056349137","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6502193,0.11707681,0.088341646,0.014076172,0.0020887584,0.0012822931,0.0009224796,0.00064961053,0.12534301],"genre_scores_gemma":[0.87615466,0.0458026,0.045253705,0.002735167,0.0009118101,0.0014817398,0.0006425369,0.00011593542,0.026901776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981457,0.000059094455,0.0000108119475,0.000040365958,0.000042079206,0.000033126387],"domain_scores_gemma":[0.99981886,0.00007501576,0.000020352532,0.0000200451,0.000022822293,0.00004291412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005543565,0.00036910194,0.00048956467,0.0003731962,0.00019331765,0.0009092725,0.0005974399,0.0008173301,0.009517099],"category_scores_gemma":[0.00051737454,0.00012329566,0.0003732081,0.0002667351,0.00039451732,0.0008492963,0.00072882615,0.0007236849,0.0011648635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006817113,0.0033196544,0.0035849106,0.003754488,0.00023528415,0.00041171873,0.00030765927,0.0017654747,0.115991056,0.025714314,0.0031320106,0.83496636],"study_design_scores_gemma":[0.0038060283,0.07999819,0.08503854,0.005242208,0.0013140262,0.0024202035,0.002274931,0.021612007,0.12626316,0.074828684,0.59695154,0.00025053718],"about_ca_topic_score_codex":0.00031412457,"about_ca_topic_score_gemma":0.00038507025,"teacher_disagreement_score":0.009517099,"about_ca_system_score_codex":0.00018678718,"about_ca_system_score_gemma":0.00032376937,"threshold_uncertainty_score":0.03183788},"labels":[],"label_agreement":null},{"id":"W2065097064","doi":"10.2174/1568007033338832","title":"Osteoporosis in Anorexia Nervosa: A Brittle Future","year":2003,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Anorexia nervosa; Osteopenia; Osteoporosis; Medicine; Anorexia; Pediatrics; Endocrinology; Internal medicine; Eating disorders; Psychiatry; Bone mineral","score_opus":0.04091482381570872,"score_gpt":0.3522683560232328,"score_spread":0.3113535322075241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065097064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000102345,0.99785894,0.000053460655,0.0010205257,0.00018595242,0.000002011906,0.0000031253867,0.0000034271752,0.00077018805],"genre_scores_gemma":[0.0008392544,0.997647,0.00011929478,0.0005273828,0.00028504757,0.0000036518616,0.000004747697,6.87226e-7,0.00057289004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976236,0.00006480411,0.00003570011,0.000026498386,0.00009233424,0.000018176384],"domain_scores_gemma":[0.99965274,0.00016507218,0.00004923182,0.000011289536,0.00008401092,0.000037607282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006264067,0.00060100044,0.001233324,0.0014584159,0.00047811263,0.0010582871,0.0005772078,0.0022000712,0.0023883793],"category_scores_gemma":[0.0006848325,0.00026676638,0.00034580546,0.0015800844,0.0010988567,0.0017498719,0.0006099973,0.0022093682,0.0012699334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065785294,0.00008256015,0.00060079724,0.008685118,0.000055989774,0.0006500762,0.00019938264,0.00019625705,0.00053822563,0.004526381,0.030778803,0.9536208],"study_design_scores_gemma":[0.000041370968,0.0002382511,0.0056473985,0.012076725,0.000109164015,0.011151238,0.00071774144,0.00015162067,0.00020431764,0.008981981,0.9606445,0.000035594894],"about_ca_topic_score_codex":0.0025097465,"about_ca_topic_score_gemma":0.006757188,"teacher_disagreement_score":0.0025097465,"about_ca_system_score_codex":0.0008203392,"about_ca_system_score_gemma":0.0018849048,"threshold_uncertainty_score":0.007989943},"labels":[],"label_agreement":null},{"id":"W2072477505","doi":"10.2174/156800705774322058","title":"CREB, Synapses and Memory Disorders: Past Progress and Future Challenges","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"CREB; Neuronal memory allocation; Neuroscience; Long-term potentiation; Aplysia; Synaptic plasticity; Transcription factor; Biology; Neuroplasticity; Cell biology; Metaplasticity; Gene; Genetics; Receptor","score_opus":0.021891309593915415,"score_gpt":0.29220355067183246,"score_spread":0.27031224107791707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072477505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057076246,0.9984901,0.0000725869,0.00069860864,0.00024470902,0.0000012396472,0.000005513877,0.000005175887,0.0004249446],"genre_scores_gemma":[0.00045272484,0.99802774,0.0001691035,0.0003681069,0.00040261116,0.0000033296783,0.000011050977,0.0000012311272,0.00056410267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998623,0.00003188323,0.000020344994,0.000023124448,0.00004506379,0.000017227343],"domain_scores_gemma":[0.99951553,0.00024619928,0.000038189974,0.000016161632,0.00011230547,0.0000715168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008266246,0.0009008654,0.0015262803,0.001513274,0.0004166722,0.0010956221,0.0010211996,0.0019182905,0.003534638],"category_scores_gemma":[0.00085706037,0.00025728546,0.00036400108,0.0016526845,0.0007919457,0.0024167164,0.00077912357,0.0019885595,0.0021052323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001249814,0.000085218846,0.00019009793,0.008348108,0.0000638948,0.00033085851,0.00008924082,0.00035828166,0.0012153147,0.005359847,0.05247351,0.93136066],"study_design_scores_gemma":[0.0000284428,0.00012787555,0.0009030332,0.0030913185,0.0000770474,0.0016966682,0.00017482182,0.00011975619,0.0003194988,0.007145349,0.9862948,0.000021333677],"about_ca_topic_score_codex":0.0011994434,"about_ca_topic_score_gemma":0.0027457895,"teacher_disagreement_score":0.003534638,"about_ca_system_score_codex":0.00086538465,"about_ca_system_score_gemma":0.0012573717,"threshold_uncertainty_score":0.011824548},"labels":[],"label_agreement":null},{"id":"W2112341182","doi":"10.2174/1568007023338914","title":"Galanin: A Biologically Active Peptide","year":2002,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Galanin; Galanin receptor; Neuropeptide; Internal medicine; Endocrinology; Biology; Central nervous system; Receptor; Medicine","score_opus":0.08688973407603384,"score_gpt":0.3283329591641141,"score_spread":0.24144322508808025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112341182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24566452,0.5508885,0.03994303,0.0046542156,0.006097843,0.0006610071,0.004791512,0.0031047047,0.14419474],"genre_scores_gemma":[0.7060517,0.17145085,0.013184637,0.0035693585,0.0013593078,0.00030358054,0.0049207965,0.0002453411,0.09891436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982774,0.000019667053,0.000011356482,0.00003587867,0.0000732517,0.000032040447],"domain_scores_gemma":[0.99994886,0.000004061054,0.000010560812,0.000002678225,0.000011051541,0.00002265435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013307048,0.0006610873,0.00032244818,0.0006454591,0.00028994514,0.0011215231,0.0003523879,0.0007279526,0.0038392195],"category_scores_gemma":[0.00015739513,0.00008715474,0.00022240449,0.0006368467,0.00055132346,0.00061787694,0.00073994586,0.0007432912,0.0035891407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009734532,0.00027595603,0.0026694415,0.0023922613,0.00007072462,0.001810766,0.0001598169,0.00048230507,0.46407998,0.007094901,0.023456503,0.49653387],"study_design_scores_gemma":[0.00007600996,0.0008170376,0.008645721,0.00031392497,0.00006866031,0.006649139,0.00013640597,0.00040001696,0.16607903,0.0033850076,0.81337714,0.000051915726],"about_ca_topic_score_codex":0.00028896658,"about_ca_topic_score_gemma":0.00012946506,"teacher_disagreement_score":0.0038392195,"about_ca_system_score_codex":0.00042758413,"about_ca_system_score_gemma":0.00031200604,"threshold_uncertainty_score":0.01284349},"labels":[],"label_agreement":null}]}